Creating new antibiotics to fight resistant bacteria
Development of peptide nucleic acid antibiotics
This study is working on creating new antibiotics to help fight tough infections caused by a bacteria called Klebsiella pneumoniae, which can lead to serious lung problems, especially for patients who are already at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nubad, LLC NIH-funded |
| Lab location | 1 site (Greer, United States) |
| Project ID | NIH-10762416 on NIH RePORTER |
What this research studies
This research focuses on developing innovative peptide nucleic acid antibiotics to combat antimicrobial resistance, particularly against Klebsiella pneumoniae, a bacteria that can cause severe lung infections. The approach involves designing new classes of antibiotics that can effectively target and inhibit resistant bacterial strains. By addressing the urgent need for effective treatments against superbugs, this research aims to improve patient outcomes in the face of rising antibiotic resistance. Patients with bacterial infections, especially those at risk from viral lung infections, may benefit from these new antibiotics.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with infections caused by Klebsiella pneumoniae or other resistant bacterial strains.
Not a fit: Patients with viral infections that do not involve bacterial co-infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new treatment options for patients suffering from antibiotic-resistant bacterial infections.
How similar studies have performed: Other research has shown promise in developing new antibiotics to combat resistant bacteria, indicating that this approach has potential for success.
Where this research is happening
Greer, United States
- Nubad, LLC — Greer, United States (Active)
Researchers
- Principal investigator: Arya, Dev Priya — Nubad, LLC
- Study coordinator: Arya, Dev Priya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.